TP53 and neoplasm: Cytotoxicity against all cell lines except against HeLa (especially effective against HL-60 cells (50 μM). Clonogenic inhibition ability of all tested tumor cells. Accumulation in S-phase at expense of G1/G0-phase. Lower incidence in p53-deficient cells.